ResMed dividend yield RMD
Dividends per share over the last twelve months divided by the share price, since 2012.
- Today, Oct 23, 2026
- 0.97%
- 10-year median
- 0.9%
- Against its 10-year history
- 53rd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 0.5% to 2.2%
- Peer median
- 1.1%
ResMed pays 0.97% of its share price in dividends over a year, as of Oct 23, 2026.
That is above its ten-year median of 0.9%, close to the middle of its last ten years.
Over that time it ranged from 0.5% in Sep 2021 to 2.2% in Nov 2016.
The median for 10 medical instruments and supplies stocks of a similar size is 1.1%.
Dividend yield over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 1.0% | 0.8% | 1.3% |
| 2025 | 0.9% | 0.7% | 1.0% |
| 2024 | 0.9% | 0.8% | 1.1% |
| 2023 | 1.1% | 0.7% | 1.3% |
| 2022 | 0.8% | 0.6% | 0.9% |
| 2021 | 0.6% | 0.5% | 0.8% |
| 2020 | 0.7% | 0.7% | 1.3% |
| 2019 | 1.0% | 1.0% | 1.5% |
| 2018 | 1.3% | 1.2% | 1.6% |
| 2017 | 1.6% | 1.6% | 2.0% |
| 2016 | 2.0% | 1.7% | 2.2% |
| 2015 | 2.2% | 1.5% | 2.3% |
| 2014 | 1.8% | 1.8% | 2.2% |
| 2013 | 1.8% | 0.7% | 1.8% |
| 2012 | 0.8% | 0.4% | 0.9% |
Against its peers
Companies in Medical - Instruments & Supplies nearest ResMed's size, closest first, today.
| Company | Dividend yield |
|---|---|
| RMDResMed | 0.97% |
| MDLNMedline | n/m |
| WSTWest Pharmaceutical Services | 0.22% |
| BDXBecton, Dickinson and | 2.00% |
| SOLVSolventum | n/m |
| PENPenumbra | n/m |
| COOCooper Companies | n/m |
| ALGNAlign Technology | n/m |
| GMEDGlobus Medical | n/m |
| PODDInsulet | n/m |
| ISRGIntuitive Surgical | n/m |
| Peer median | 1.11% |
Where ResMed ranks
What the dividend yield tells you
Yearly dividends per share divided by the share price.
A yield that suddenly looks high often means the price fell because the dividend is at risk.
More on ResMed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.